Paul L. Martin

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner et al. · New England Journal of Medicine · 2018 · 5.6K citations · Full text

Medicine, Hematology, Oncology +17

[36] Eukaryotic gene transcription with purified components

John David Dignam, Paul L. Martin, Barkur S. Shastry et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 1983 · 989 citations

Life Sciences, Genetics, Molecular Biology +12

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

Michael J. Borowitz, Meenakshi Devidas, Stephen P. Hunger et al. · Blood · 2008 · 835 citations · Full text

Medicine, Oncology, Pediatrics +15

Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma

Marcelo C. Pasquini, Zhen‐Huan Hu, Kevin J. Curran et al. · Blood Advances · 2020 · 434 citations · Full text

Medicine, Hematology, Oncology +17

Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial

Theodore W. Laetsch, Shannon L. Maude, Susana Rives et al. · Journal of Clinical Oncology · 2022 · 357 citations · Full text

Medicine, Hematology, Oncology +17